Address	Fraunhoferstrasse 22 Planegg-Martinsried Bayern (Bavaria) 82152 Germany
Employees	-
Website	http://www.4sc.de
Updated	07/08/2019
4SC AG engages in the development of small molecule drugs that targets cancer through epigenetic mechanisms. It also involves in the preclinical and clinical development of its products. Its assets are resminostat, 4SC-202, and 4SC-208.